aztreonam and nab741

aztreonam has been researched along with nab741 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coleman, S; Eckburg, PB; Farinola, N; Keutzer, T; Kopp, E; Lister, T; Tomayko, J; Utley, L; Walpole, S	1

Trials

1 trial(s) available for aztreonam and nab741

Article	Year
Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Area Under Curve; Aztreonam; beta-Lactams; Ceftazidime; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Piperacillin, Tazobactam Drug Combination	2019

Article

Year

Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.

Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9

Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Area Under Curve; Aztreonam; beta-Lactams; Ceftazidime; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Piperacillin, Tazobactam Drug Combination

2019